Epidemiology of community-acquired pneumonia (CAP)

Antoni Torres Marti (Barcelona, Spain)

Source: International Congress 2015 – Russia Day: Community-acquired pneumonia (CAP) in adults
Session: Russia Day: Community-acquired pneumonia (CAP) in adults
Session type: Session
Number: 51
Disease area: Respiratory infections

WebcastSlide presentationMultimedia files

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Antoni Torres Marti (Barcelona, Spain). Epidemiology of community-acquired pneumonia (CAP). International Congress 2015 – Russia Day: Community-acquired pneumonia (CAP) in adults

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Biomarkers in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012

Epidemiology of community-acquired pneumonia and nosocomial pneumonia
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006



Legionella pneumonia in patients hospitalized with community-acquired pneumonia (CAP) in Norway
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012

Healthcare-associated pneumonia: Comparative characteristics with community-acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015

Biomarkers and severity in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012


Atypical agents of community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 485s
Year: 2003

Nosocomial pneumonia (non-ventilator-acquired)
Source: International Congress 2014 – PG16 Low respiratory tract infections: learning from real clinical cases
Year: 2014




Use of ceftriaxone/sulbactame for treatment of mild-to-severe community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009

Role of virus in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012

Etiology of community-acquired pneumonia (CAP) in young hospital patients
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002

Update on community-acquired pneumonia
Source: International Congress 2017 – ME5 Update on community-acquired pneumonia
Year: 2017


Community-acquired pneumonia (CAP) and pregnancy
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009


Epidemiology of community- and hospital-acquired pneumonia
Source: Annual Congress 2003 - PG11 - Pneumonia epidemiology and diagnosis
Year: 2003

Are there radiographic differences between patients with community-acquired (CAP) and healthcare-associated pneumonias (HCAP)?
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010


Epidemiology of antibiotics prescribtion for treatment of hospital-acquired pnemonia (HAP) in ICU
Source: Eur Respir J 2004; 24: Suppl. 48, 547s
Year: 2004

Clinical failure in community-acquired pneumonia
Source: International Congress 2014 – PG16 Low respiratory tract infections: learning from real clinical cases
Year: 2014




Influence of comorbidities on pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013


Mixed community-acquired pneumonia in hospitalised patients
Source: Eur Respir J 2006; 27: 795-800
Year: 2006